Skip to main content
OpenTrials

Clinical trial condition

Arteriosclerosis

Explore clinical trials studying Arteriosclerosis. Study availability and eligibility vary by location and protocol.

72 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Arteriosclerosis trial results

Completed

RESOLUTE China Registry:

NCT01243749

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +13 more
Locations
  • Beijing Fumwai Hospital Beijing, China
  • Peiking University People's Hospital Beijing, China
  • Fujian Medical University Union Hospital Fuzhou, China
  • Guangdong Provincial People's Hospital Guangdong, China
View Trial Details
Completed

Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial

NCT02510547

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Minneapolis Heart Institute Minneapolis, Minnesota, United States
  • United Heart and Vascular Clinic and United Hospital Saint Paul, Minnesota, United States
View Trial Details
Completed

RESOLUTE China RCT

NCT01334268

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +13 more
Locations
  • An Zhen Hospital Beijing, Beijing Municipality, China
  • Beijing Fu Wai Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • First Affiliated Hospital of Medical College of XI'AN Jiaotong University Xi'an, Shaanxi, China
View Trial Details
Completed

The FAVOR II China Study

NCT03191708

Conditions
Angina Pectoris, Arterial Occlusive Diseases, Arteriosclerosis, +11 more
Locations
  • Fuwai Hospital Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • Guangdong General Hospital Guangzhou, China
View Trial Details
Completed

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

NCT01583608

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +7 more
Locations
  • Medical Care Center Prof. Mathey, Prof. Schofer GmbH Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Herzzentrum Brandenburg in Bernau Bernau, Germany
  • Klinikum Coburg GmbH Coburg, Germany
  • Elisabeth-Krankenhaus Essen GmbH Essen, Germany
View Trial Details

Related conditions